CLINICAL_TRIALS
ClinicalTrials.gov record update
A Single Arm Phase 2 Study of Talimogene Laherparepvec in Patients With Cutaneous Squamous Cell Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03714828
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:08.832905+00:00
- Published At
- 2024-10-09T00:00:00+00:00
- Record Updated At
- 2024-10-09
- Results Posted At
- 2024-10-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Squamous Cell Carcinoma", "Skin Cancer", "Keratoacanthoma", "Cutaneous Tumor", "Skin Cancer, Squamous Cell", "Lesion Skin"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-10-09"- protocolSection.identificationModule.nctId
"NCT03714828"- protocolSection.identificationModule.officialTitle
"A Single Arm Phase 2 Study of Talimogene Laherparepvec in Patients With Cutaneous Squamous Cell Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-10-09"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.